Effectiveness and Safety of Zercepac and Reference Trastuzumab in the Neoadjuvant Setting for Early-Stage Breast Cancer: A Retrospective Cohort Study

Figure 3

Detailed pathological response to treatment in patients who received reference trastuzumab and Zercepac.